A narrative review of lifestyle management guidelines for metabolic dysfunction–associated steatotic liver disease
Dana Ivancovsky‐Wajcman(Barcelona Institute for Global Health), Jeffrey V. Lazarus(The Graduate Center, CUNY), Alina M. Allen(Mayo Clinic in Arizona), Javier Crespo(Marqués de Valdecilla University Hospital), Lynn H. Gerber(Inova Health System), John Dillon(University of Dundee), Christopher J. Byrne(NHS Tayside), Zobair M. Younossi(Inova Health System), Marcela Villota‐Rivas(Barcelona Institute for Global Health), Paul Brennan(Ninewells Hospital)
Cited by 29
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k